Please share what your organisation and Boehringer Ingelheim will Co-Create together
Boehringer has established itself as a lead innovator in the pharmaceutical sector while EyeCheck exists to enhance quality of life by building the most powerful diagnostic tool in the market. Through co-creation of our diagnostic tools, Boehringer can also prevent the conditions that it is treating with its pharmaceutical programs. Together we can resolve more health issues and be on the forefront of consumer-centered diagnostics. EyeCheck’s core technology can help to ensure earlier detection and earlier opportunity for BI products to be delivered to the right people.
If you selected "other" above, please explain:
Please provide a 1-2 sentence summary of your Co-Creation idea
We are building affordable vision diagnostic tools that are faster, more mobile, and easier to use than anything else on the market. The first generation of our hardware diagnostic tool will have the potential to identify prescription needs and various eye health issues such as cataracts.
How does this project link to the core mission of your organisation?
Our mission is to break down time, distance, and financial barriers to provide a future for everyone to see clearer. With the creation of our vision diagnostic tools, this will enable us to fulfill the core mission of our organization. Our technology will be used in healthcare settings and eye camps around the world, allowing 10x the amount of patients to be seen per day. Patients will be able to get their eyes tested by anyone who has access to our technology.
Beyond social impact, how does this project link to Boehringer Ingelheim’s core business?
Our vision is to become a leader in eye care through our innovations. This aligns with BI’s vision of “Lead and Learn” delivered through “Value through innovation”. We also align with BI because we continually seek to learn, expand, and find more opportunities to collaborate and develop further.
What are the specific inputs and actions that each side will contribute to this Co-Creation idea based on each of your unique competencies and experiences?
My organization will contribute: We will allow BI to tailor the scope of our hardware devices development (ie suggesting diseases to identify) which will allow Boehringer to expand the methods that it provides care. EyeCheck can be the backbone on which a whole host of guided therapies can be delivered.
Boehringer Ingelheim will contribute: The co-creation opportunity would make use of veteran knowledge in the company to advance a culture and history of making a difference. By giving EyeCheck access to large data sets which will help us build and perfect our technology to ensure users are getting a proper diagnosis.
Please describe the potential revenue model for this Co-Creation idea.
EyeCheck’s revenue model is sustainable. Currently, our hardware prototype costs less than a tenth of our competitors. Over time, we believe that our finished product will remain more affordable than our competitor’s products while building a larger margin for the company as economies of scale develop. The first generation of our hardware diagnostic tool will have the potential to identify prescription needs and various eye health issues such as cataracts. Pre-sales would be in Spring 2016. At that time, we will be finishing up our beta testing phase and will use the beta phase to kick start pre-sales. It will be a one-time purchasing fee, with optional paid software upgrades in the future.
What possible risks or challenges do you foresee?
EyeCheck’s future is not free of barriers. We are creating a technology, which will have to conform to international health and safety standards as well as certain local standards. We mitigate this risk by working with experts from health delivery and vision science very early and often. We also work with people who have carried out similar projects (i.e. Engineers without Borders). With them we have held ourselves to a high standard of safety and accuracy. Another major barrier is in identifying delivery partners, who can scale with our goals of changing vision care across the planet.
Is there anything else you would like to share about your Co-Creation idea?
If you selected "other" above, please explain:
Besides Boehringer Ingelheim, what other types of partners might be valuable to carrying out your Co-Creation idea, and why?
United Health Group, Kaiser Foundation Group, Wellpoint Inc. Group, Aetna Group, Lions and Rotary Clubs, Orbis International, United Nations, Humana Group, Helen Keller, Optometry Giving Sight, WHO, The Fred Hallows Foundation, CNIB, Prevent Blindness, Health Savers, Mayo Clinic, The Cleveland Clinic, Sunnybrook Health Sciences Center and Mount Sinai.